TY - JOUR
T1 - Synthesis of some novel D-glucuronic acid acetylated derivatives as potential anti-tumor agents
AU - El-Nezhawy, Ahmed O.H.
AU - Adly, Frady G.
AU - Eweas, Ahmed F.
AU - Hanna, Atef G.
AU - El-Kholy, Yehya M.
AU - El-Sayed, Shahenaz H.
AU - El-Naggar, Tarek B.A.
PY - 2011/10
Y1 - 2011/10
N2 - A structurally diverse series of Δ 4,5-uronamide derivatives have been chemically synthesized starting from D-glucuronic acid itself by means of acetylation, activation, amide bond formation and base-catalyzed elimination protocols. Structure elucidation for all products along with optimization of the synthetic steps is described. The synthesized compounds were evaluated for their in-vitro anti-tumor activity against MCF-7, TK-10 and UACC-62 cell lines. The compounds 5, 11, 13, 15 and 16 were the most active against TK-10 cell line. On the other hand, the most active compounds against the MCF-7 cell line were 11 and 15. However, compounds 5, 7, 11, 13, 15 and 16 were the most active against the UACC-62 cell line.
AB - A structurally diverse series of Δ 4,5-uronamide derivatives have been chemically synthesized starting from D-glucuronic acid itself by means of acetylation, activation, amide bond formation and base-catalyzed elimination protocols. Structure elucidation for all products along with optimization of the synthetic steps is described. The synthesized compounds were evaluated for their in-vitro anti-tumor activity against MCF-7, TK-10 and UACC-62 cell lines. The compounds 5, 11, 13, 15 and 16 were the most active against TK-10 cell line. On the other hand, the most active compounds against the MCF-7 cell line were 11 and 15. However, compounds 5, 7, 11, 13, 15 and 16 were the most active against the UACC-62 cell line.
KW - Amide linkage
KW - Anti-tumor
KW - D-Glucuronamide
KW - D-Glucuronic acid
KW - MCF-7
KW - TK-10
KW - UACC-62
UR - http://www.scopus.com/inward/record.url?scp=80054007351&partnerID=8YFLogxK
U2 - 10.1002/ardp.201000367
DO - 10.1002/ardp.201000367
M3 - Article
C2 - 21984015
AN - SCOPUS:80054007351
SN - 0365-6233
VL - 344
SP - 648
EP - 657
JO - Archiv der Pharmazie
JF - Archiv der Pharmazie
IS - 10
ER -